Swarajya

Our View
HeadlinesMagazineVideosBooksस्वराज्यEconomyCultureEvents
User Profile
Subscribe
Swarajya
Subscribe
  • Our View
  • Headlines
  • Magazine
Swarajya
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief
  • Subscriber login
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief

AstraZeneca

Explained: The Debate Over If, When And How Of Covid-19 Vaccine Booster Shots In India
Explained: The Debate Over If, When And How Of Covid-19 Vaccine Booster Shots In IndiaSwarajya StaffDec 15, 2021 12:18 PM +05:30 IST
Why I Think mRNA Vaccines Are Not The Best Choice For Booster Doses
Why I Think mRNA Vaccines Are Not The Best Choice For Booster Doses Amit ThadaniDec 12, 2021 02:15 PM +05:30 IST
Oxford-Based Experts Among Others Share Their Views On Whether Vaccines Will Protect Against Omicron
Oxford-Based Experts Among Others Share Their Views On Whether Vaccines Will Protect Against OmicronBhaswati Guha Majumder Dec 1, 2021 03:04 PM +05:30 IST
Booster Doses? Vaccination For Children? SUTRA Team Answers Your Questions
Booster Doses? Vaccination For Children? SUTRA Team Answers Your QuestionsThe SUTRA TeamNov 10, 2021 11:43 AM +05:30 IST
AstraZeneca Enters The Crowded Field Of Covid-19 Medicines With Its Antibody Cocktail
AstraZeneca Enters The Crowded Field Of Covid-19 Medicines With Its Antibody Cocktail Bhaswati Guha Majumder Oct 13, 2021 03:32 PM +05:30 IST
UK Updates List Of Vaccines To Accept Covishield; Still No Clarity On Acceptance Of CoWIN Certificate
UK Updates List Of Vaccines To Accept Covishield; Still No Clarity On Acceptance Of CoWIN CertificateSwarajya StaffSep 22, 2021 01:46 PM +05:30 IST
Vaccines Are Helping The World To Combat Covid-19 But This Pandemic Battle Needs Better Strategy
Vaccines Are Helping The World To Combat Covid-19 But This Pandemic Battle Needs Better Strategy Bhaswati Guha Majumder Aug 24, 2021 05:14 PM +05:30 IST
 AstraZeneca Says New Data Demonstrates 92 Per Cent Vaccine Effectiveness Against Delta Variant  
AstraZeneca Says New Data Demonstrates 92 Per Cent Vaccine Effectiveness Against Delta Variant  IANSJun 23, 2021 03:52 PM +05:30 IST
AstraZeneca And Sputnik V Makers Give Positive Response Over Telangana Govt's Global Tender For COVID Vaccine Supply
AstraZeneca And Sputnik V Makers Give Positive Response Over Telangana Govt's Global Tender For COVID Vaccine SupplySwarajya StaffMay 28, 2021 12:56 PM +05:30 IST
S Jaishankar To Visit US Next Week To Seal Deals On Covid-19 Vaccine Supplies
S Jaishankar To Visit US Next Week To Seal Deals On Covid-19 Vaccine SuppliesSwarajya StaffMay 22, 2021 05:04 PM +05:30 IST
50 Lakh Covishield Doses Earmarked For Export To UK To Now Be Used For Vaccinating 18-44 Age Group In India
50 Lakh Covishield Doses Earmarked For Export To UK To Now Be Used For Vaccinating 18-44 Age Group In IndiaSwarajya StaffMay 8, 2021 08:34 AM +05:30 IST
Sweden Planning To Donate One Million Doses of AstraZeneca COVID-19 Vaccines To India
Sweden Planning To Donate One Million Doses of AstraZeneca COVID-19 Vaccines To IndiaSwarajya StaffMay 4, 2021 09:25 AM +05:30 IST
WHO Approves Moderna Covid-19 Vaccine For Emergency Use, Fifth Jab To Receive Validation From Global Health Body
WHO Approves Moderna Covid-19 Vaccine For Emergency Use, Fifth Jab To Receive Validation From Global Health BodyIANSMay 1, 2021 12:58 PM +05:30 IST
Raw Materials Are Not Needed For Manufacturing Of Covishield, But For Covovax, Serum Institute To US Govt
Raw Materials Are Not Needed For Manufacturing Of Covishield, But For Covovax, Serum Institute To US GovtSwarajya StaffMay 1, 2021 09:49 AM +05:30 IST
US Likely To Send 20 Million Doses Of Covid-19 Vaccine To India From Its AstraZeneca Order: Report
US Likely To Send 20 Million Doses Of Covid-19 Vaccine To India From Its AstraZeneca Order: ReportSwarajya StaffApr 30, 2021 08:09 AM +05:30 IST
Vaccinomics 1.0:  There Is No Free Lunch Even When It Comes To Life-Savers
Vaccinomics 1.0: There Is No Free Lunch Even When It Comes To Life-SaversR JagannathanApr 22, 2021 11:31 AM +05:30 IST
How Bharat Biotech Plans To Overcome Production Challenges Due To Export Restrictions On Raw Materials By US        
How Bharat Biotech Plans To Overcome Production Challenges Due To Export Restrictions On Raw Materials By US       Bhaswati Guha MajumderApr 15, 2021 02:27 PM +05:30 IST
India’s Covid Critics Are Back:  They Are Right For Now, But Will Be Proved Wrong Again
India’s Covid Critics Are Back: They Are Right For Now, But Will Be Proved Wrong AgainR JagannathanApr 15, 2021 11:37 AM +05:30 IST
US Stops Production Of AstraZeneca's COVID-19 Vaccines At A Baltimore-Based Vaccine Maker's Facility
US Stops Production Of AstraZeneca's COVID-19 Vaccines At A Baltimore-Based Vaccine Maker's FacilitySwarajya StaffApr 5, 2021 11:06 AM +05:30 IST
Canadian Committee On Immunization Recommends Pause On AstraZeneca Covid-19 Vaccine For People Younger Than 55 Years
Canadian Committee On Immunization Recommends Pause On AstraZeneca Covid-19 Vaccine For People Younger Than 55 YearsSwarajya StaffMar 30, 2021 10:02 AM +05:30 IST
Load More

About Swarajya

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Fact Check
  • Gift Swarajya
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Advertise
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.Artboard 2 Copy 10Created with Sketch.Artboard 2 Copy 7Created with Sketch.Artboard 2 Copy 9Created with Sketch.
Copyright: Swarajya. All Rights Reserved.
Powered by Quintype